Jeffrey S. Farrow - Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer and Chief Strategy Officer
Issuer Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey S. Farrow - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Jeffrey S. Farrow for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 30,724 $1,795,733 $10.99 05 Mar 2026 Direct Common Stock
Common Stock 36,704 $1,483,575 $40.42 17 Jun 2025 Direct
Restricted Stock Units 19,306 $310,133 $12.89 05 Mar 2026 Direct Common Stock

Transactions reported by Jeffrey S. Farrow for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.